Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
CommentaryAttorney Analysis from Westlaw Today, a part of Thomson Reuters. October 08, 2025 - Stories of lawyers submitting AI-hallucinated caselaw to courts have become ubiquitous in 2025. Most ...
Officials estimate that pythons have killed 95% of small mammals as well as thousands of birds in Everglades National Park South Florida Water Management District via AP; AP Photo/Lynne Sladky ...
Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...
I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...
In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...
Running Python scripts is one of the most common tasks in automation. However, managing dependencies across different systems can be challenging. That’s where Docker comes in. Docker lets you package ...
Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...
Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results